An exploration into Injective, an L1 built with the Cosmos SDK.
Written by Greythorn Asset Management
31 Jul 2023
22 mins read
Injective is a Layer 1 blockchain built upon the Cosmos network. Its architecture is designed to reduce congestion and utilise a gas-free model for users to trade. All market maker and taker fees are to be paid with INJ, its native token.
Injective Bridge allows users to easily transfer their tokens from Ethereum to the Injective chain. This helps create a link between Cosmos and Ethereum.
Injective does not use Automated Market Makers. Instead, it uses the order book model found on centralised exchanges to reduce latency. This is in line with its mission to bring together scalability and decentralisation to the cryptocurrency derivatives market.
How does it work?
There are several financial applications already offered through Injective, including: 1. Auctions: INJ token holders may bid on baskets of tokens. Users can hence receive/sell at fairer prices based on the demand for the group of assets.
Figure 1. Auctions on Injective, Source: Injective Auction
2. DEX: Exchange applications built upon Injective (such as Helix), where users can trade both spot and derivative products.
Injective also contains a built-in solution to eliminate trade front-running called a Trade Execution Coordinator, which organises delays to prevent new orders from being able to be placed ahead of old ones.
3. Insurance: Watch derivative market is required to have an insurance fund, and underwriters in creating these. Users can put forth the amount that they would like to underwrite and request redemption for the insurance product.
Figure 2. Insurance Markets on Injective, Source: Injective Insurance Fund
4. Oracle Feeds
5. Peggy: The Injective Bridge. When it was first released, INJ experienced a >100% gain in its trading price.
Figure 5: Injective Tokenomics, Source: Greythorn Research Team, Data: Coin98
~80% of the token supply has already been unlocked, with the following upcoming vesting events:
August 21st 2023: 3.02% of supply.
January 21st 2024: 3.67% of supply.
Multi VM Chains
Injective Orbital Chains
Mesh Chain Network
Automated Market Makers (AMMs) are usually preferred over traditional order books for reasons of decentralisation, however, order books can be preferred as they reduce slippage for larger orders. Injective uses these order books while still offering decentralisation, which is likely to hold a degree of attractiveness in a market that is oversaturated with AMMs and less so with order book DEXs.D
Growing user base.
Figure 6: Total Injective Users, Source: @mzs8 Dune Analytics
Figure 7: Total Addresses, Source: @mzs8 Dune Analytics
LT Deflation: As a deflationary mechanism, Injective burns 60% of all exchange fees every week in the form of INJ tokens.
Its solutions around preventing trade front-running may assist in a more welcoming regulatory stance for its exchange products.
Injective has seen a drop since late 2020 in the amount of weekly active users. Its growth this year does not necessarily indicate that the number of users will continue to grow as only around half of the users are old, suggesting that Injective potentially may have difficulty retaining users.
Figure 8: Weekly Active Users, Source: @scaneth Dune Analytics
INJ inflation was targeted to be 7%, with a slow decrease to 2% over time. However, its current supply inflation is 23.08%. This appears to be due to significant inflation in the past few months, with market cap increasing at a significantly higher rate than the price. This follows the fact that the protocol unlocked 3-4% of the total supply during three separate events on the 21st of January, February and May (~9.71% in total). This may potentially indicate that the increased amount of addresses with INJ was simply due to an increased supply of INJ, which may not be sustainable from a user base perspective.
Within the token distribution, there is only 9% allocated for public sale. The rest of the allocation is generally to reward ‘insiders’, including contributors, team members and private investors. This may that the allocation of the token is quite centralised.
Injective offers a range of financial applications, including auctions, DEX trading, insurance markets, and an innovative solution to prevent trade front-running through the Trade Execution Coordinator.
While the project shows bullish fundamentals such as a growing user base and LT deflation through fee burning, it also faces challenges. The drop in weekly active users since late 2020 raises concerns about user retention. Additionally, the current supply inflation is higher than initially targeted, and the token distribution may be perceived as centralised.
Looking ahead, Injective has a promising roadmap, with planned upgrades and multi-chain implementations in the coming quarters. As the platform evolves, it will be crucial to address the challenges while leveraging its unique offerings to solidify its position in the competitive DeFi space.
About | Injective is pioneering a new world of Web3. (n.d.). Injective. Retrieved June 26, 2023, from https://injective.com/about
Chaseling, B. (2023, May 29). What is Injective? Breaking Down the Borderless DeFi Protocol. Zerocap. Retrieved June 26, 2023, from https://zerocap.com/research-lab/what-is-injective-defi-protocol/
CoinGecko. 2023. Cryptocurrency Prices, Charts, and Crypto Market Cap | CoinGecko. [online] Available at: <https://www.coingecko.com/> [Accessed 23 June 2023].
CoinMarketCap. 2023. Cryptocurrency Prices, Charts And Market Capitalizations | CoinMarketCap. [online] Available at: <https://coinmarketcap.com/> [Accessed 23 June 2023].
DefiLlama. 2023. DefiLlama. [online] Available at: <https://defillama.com/> [Accessed 23 June 2023].
Crypto_dazzy. (2023, May 16). Analyzing the Tokenomics of Injective Protocol | by Crypto_dazzy | May, 2023. Medium. Retrieved June 26, 2023, from https://medium.com/@pexcyekong/analyzing-the-tokenomics-of-injective-protocol-4410e1c32d5f
dYdX (DYDX). (n.d.). DefiLlama. Retrieved June 26, 2023, from https://defillama.com/protocol/dydx
dYdX price today, DYDX to USD live price, marketcap and chart. (n.d.). CoinMarketCap. Retrieved June 26, 2023, from https://coinmarketcap.com/currencies/dydx/
Finneseth, J. (2022, February 13). Injective Protocol (INJ) rallies 100%+ after launching cross-chain support for Cosmos. Cointelegraph. Retrieved July 5, 2023, from https://cointelegraph.com/news/injective-protocol-inj-rallies-100-after-launching-cross-chain-support-for-cosmos
Hussey, M., & Tran, C. (2020, April 29). What is Synthetix? Decrypt. Retrieved June 26, 2023, from https://decrypt.co/resources/what-is-synthetix-explained-ethereum-trading-learn
Injective. (n.d.). CoinMarketCap. Retrieved June 26, 2023, from https://coinmarketcap.com/currencies/injective/
Injective. (n.d.). Insurance Funds. Injective DOCS. Retrieved June 28, 2023, from https://docs.injective.network/learn/injective-hub/insurance
Injective Bridge. (n.d.). DefiLlama. Retrieved June 26, 2023, from https://defillama.com/protocol/injective-bridge
Injective Hub. (n.d.). Auction. Injective Hub - Auction. Retrieved July 31, 2023, from https://hub.injective.network/auction/
Injective (INJ) Price, Chart, Value & Market Cap. (n.d.). CoinCodex. Retrieved June 26, 2023, from https://coincodex.com/crypto/injective-protocol/
Injective Labs. (2021, December 10). Injective Burn Auction Launch. Injective Blog. Retrieved June 26, 2023, from https://blog.injective.com/injective-burn-auction-launch/
Injective Labs. (2022, January 28). Injective Bridge V2 Release: Cross-Chain Interoperability Across Cosmos and Ethereum. Medium. Retrieved June 28, 2023, from https://medium.com/injective-labs/injective-bridge-v2-release-cross-chain-interoperability-across-cosmos-and-ethereum-a1cb89d36906
Injective Price: INJ Live Price Chart & News. (n.d.). CoinGecko. Retrieved June 26, 2023, from https://www.coingecko.com/en/coins/injective
Injective Token / WETH on Ethereum / Uniswap. (n.d.). DEX Screener. Retrieved June 26, 2023, from https://dexscreener.com/ethereum/0x6c063a6e8cd45869b5eb75291e65a3de298f3aa8
[INJ] Injective Token. (n.d.). Nansen.ai. Retrieved June 26, 2023, from https://pro.nansen.ai/token-god-mode/token-pnl?token_address=0xe28b3b32b6c345a34ff64674606124dd5aceca30
INJ USD Live Chart & Injective Market Cap. (n.d.). DropsTab. Retrieved June 28, 2023, from https://dropstab.com/coins/injective-protocol/vesting
Juliano, A. (2023, March 27). dYdX Reveals Launch Date for Move From Ethereum to Cosmos. Decrypt. Retrieved June 26, 2023, from https://decrypt.co/124623/dydx-reveals-launch-date-move-ethereum-to-cosmos
Lucas. (2023, April 5). What Is Injective Protocol (INJ)? All About INJ Token. COIN98. Retrieved June 26, 2023, from https://coin98.net/what-is-injective-protocol-inj
Market making in DeFi. (2021, August 12). 0x. Retrieved July 4, 2023, from https://0x.org/post/market-making-in-defi
Mihajlović, M. (2023, May 8). What Is Injective Protocol? Shrimpy Academy. Retrieved June 26, 2023, from https://academy.shrimpy.io/post/what-is-injective-protocol
@mzs8. (n.d.). Injective Protocol(INJ) token analytics onchain. Dune Analytics. Retrieved June 26, 2023, from https://dune.com/mzs8/Injective-Protocol(INJ)-token-analytics-onchain
@Olafundzriche. (2023, June 19). Navigating the Future with Injective Roadmap: Unlocking the Potential of DeFi. Medium. Retrieved June 26, 2023, from https://medium.com/@olafundzriche/navigating-the-future-with-injective-roadmap-unlocking-the-potential-of-defi-8ebc09effe76
@scaneth. (n.d.). Injective Protocol token analytics. Dune Analytics. Retrieved June 26, 2023, from https://dune.com/scaneth/Injective-Protocol-token-analytics
The Shrimpy Team. (2023, June 15). What Is dYdX? Explaining the Popular Crypto Derivatives DEX. Shrimpy Academy. Retrieved June 26, 2023, from https://academy.shrimpy.io/post/what-is-dydx-explaining-the-popular-crypto-derivatives-dex
Synthetix. (n.d.). DefiLlama. Retrieved June 26, 2023, from https://defillama.com/protocol/synthetix
Wallet Pair Profiler: 0xf955c57f9ea9dc8781965feae0b6a2ace2bad6f3 and 0x7e233eafc76243474369bd080238fd6eb36a73ce. (n.d.). Nansen.ai. Retrieved July 4, 2023, from https://pro.nansen.ai/wallet-pair-profiler?address_a=0xf955c57f9ea9dc8781965feae0b6a2ace2bad6f3&address_b=0x7e233eafc76243474369bd080238fd6eb36a73ce
Wallet Pair Profiler: 0xf955c57f9ea9dc8781965feae0b6a2ace2bad6f3 and 0x8061d0010eaa8f6cd69b6823065c0f56861bdde4. (n.d.). Nansen.ai. Retrieved July 4, 2023, from https://pro.nansen.ai/wallet-pair-profiler?address_a=0xf955c57f9ea9dc8781965feae0b6a2ace2bad6f3&address_b=0x8061d0010eaa8f6cd69b6823065c0f56861bdde4
Wallet Profiler for Token (0x0548f59fee79f8832c299e01dca5c76f034f558e). (n.d.). Nansen.ai. Retrieved June 26, 2023, from https://pro.nansen.ai/wallet-profiler?address=0x0548f59fee79f8832c299e01dca5c76f034f558e
Wallet Profiler for Token (0xb1db3e730df1833983222130cf95139f6b563578). (n.d.). Nansen.ai. Retrieved June 26, 2023, from https://pro.nansen.ai/wallet-profiler-for-token?address=0xb1db3e730df1833983222130cf95139f6b563578&token_address=0xe28b3b32b6c345a34ff64674606124dd5aceca30
Wallet Profiler for Token (0xf955c57f9ea9dc8781965feae0b6a2ace2bad6f3). (n.d.). Nansen.ai. Retrieved July 4, 2023, from https://pro.nansen.ai/wallet-profiler-for-token?address=0xf955c57f9ea9dc8781965feae0b6a2ace2bad6f3&token_address=0xe28b3b32b6c345a34ff64674606124dd5aceca30
Warwick, K. (2023, March 11). What is Synthetix and How Does it Work? Gemini. Retrieved June 26, 2023, from https://www.gemini.com/cryptopedia/synthetix#section-how-does-synthetix-work
What is Injective? (INJ) | INJ Decentralized Financial Ecosystem. (n.d.). Kraken. Retrieved June 26, 2023, from https://www.kraken.com/learn/what-is-injective-inj
Important notice and disclaimer
This presentation has been prepared by Greythorn Asset Management Pty Ltd (ABN 96 621 995 659) (Greythorn). The information in this presentation should be regarded as general information only rather than investment advice and financial advice. It is not an advertisement nor is it a solicitation or an offer to buy or sell any financial instruments or to participate in any particular trading strategy. In preparing this document Greythorn did not take into account the investment objectives, financial circumstance or particular needs of any recipient who receives or reads it. Before making any investment decisions, recipients of this presentation should consider their own personal circumstances and seek professional advice from their accountant, lawyer or other professional adviser. This presentation contains statements, opinions, projections, forecasts and other material (forward looking statements), based on various assumptions. Greythorn is not obliged to update the information. Those assumptions may or may not prove to be correct. None of Greythorn, its officers, employees, agents, advisers or any other person named in this presentation makes any representation as to the accuracy or likelihood of fulfilment of any forward looking statements or any of the assumptions upon which they are based. Greythorn and its officers, employees, agents and advisers give no warranty, representation or guarantee as to the accuracy, completeness or reliability of the information contained in this presentation. None of Greythorn and its officers, employees, agents and advisers accept, to the extent permitted by law, responsibility for any loss, claim, damages, costs or expenses arising out of, or in connection with, the information contained in this presentation. This presentation is the property of Greythorn. By receiving this presentation, the recipient agrees to keep its content confidential and agrees not to copy, supply, disseminate or disclose any information in relation to its content without written consent.